Effect of antibiotics on bacterial resistance ecology: Role of the digestive tract;Impact des antibiotiques sur l'ecologie de la resistance bacterienne: Role du tube digestif

Medecine et Maladies Infectieuses

Volumn 30, Issue SUPPL. 3, 2000, Pages

  Andremont, A ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Antibiotic; Intestinal ecosystem; Resistant bacterium

Indexed keywords

ANTIBIOTIC AGENT; PROBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; BACTERIAL COLONIZATION; CONFERENCE PAPER; ECOSYSTEM; GASTROINTESTINAL INFECTION; MICROORGANISM;

EID: 0034194918     PISSN: 0399077X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0399-077X(00)89087-3     Document Type: Conference Paper

References (99)

1. Emori TG, Gaynes RP. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev 1993; 6 Suppl 4: 428-42.
2. Herman D, Gerding D. Antimicrobial resistance among enterococci. Antimicrob Agents Chemother 1991; 35: 1-4.
3. Courvalin P. Resistance of enterococci to glycopeptides. Antimicrob Agents Chemother 1990; 34: 2291-6.
4. Schaberg D, Culver D, Gaynes R. Major trends in the microbial etiology of nosocomial infection. Am J Med 1991; 91 Suppl 3B: 72-5.
5. Finegold S, Sutter V, Mathisen G. Normal indigenous intestinal flora. In: David Hentges J, ed. Human Intestinal Microflora in Health and Disease. London: Academic Press Inc; 1983. p. 3-31.
6. Ducluzeau R, Ladire M, CAllut C, Raibaud P, Abrams G. Antagonistic effect of extremely oxygen-sensitive clostridia from the microflora of conventional mice and of Escherichia coli against Shigella flexneri in the digestive tract of gnotobiotic mice. Infect Immun 1977; 17: 415-24.
7. Freter R, Brickner H, Fekete J, Vickerman M, Carrey K. Survival and implantation of Escherichia coli in the intestinal tract. Infect Immun 1983; 39: 686-703.
8. Ducluzeau R, Bellier M, Raibaud P. Transit digestif de divers inoculums bactériens introduits per os chez des souris axéniques et holoxéniques (conventionnelles): Effet antagoniste de la microflore du tractus gastro-intestinal. Parasiten Infekion Bakteriol Hyg 1970; 213: 533-48.
9. Van Der Waaij D. History of recognition and measurement of colonization resistance of the digestive tract as an introduction to selective gastro-intestinal decontamination. Epidemiol Infect 1992; 109: 315-26.
10. Freter R, Brickner H, Botney M, Cleven D, Aranki A. Mechanisms that control bacterial populations in continuous-flow culture models of mouse large intestinal flora. Infect Immun 1983; 39: 676-85.
11. Boureau H, Salanon C, Decaens C, Bourlioux P. Caecal localisation of the specific microbiota resistant to Clostridium difficile colonisation in gnotobiotic mice. Microbiol Ecol Health Dis 1994; 7: 111-7.
12. Corpet D, Nicolas J. Antagonistic effect of intestinal bacteria from the flora of piglets, against Clostridium perfringens in the gut of gnotoxenic mice and piglets. Zbl Bakteriol Hyg 1979; 7 Suppl: 169-74.
13. Ramare F, Nicoli J, Dabard J, Corring T, Ladire M, Gueugneau A, et al. Trypsin-dependent production of an antibacterial substance by a human Peptostreptococcus strain in gnotobiotic rats and in vitro. Appl Environ Microbiol 1993; 59: 2876-83.
14. Yurdusev N, Ladire M, Ducluzeau R, Raibaud P. Antagonism exerted by an association of a Bacteroides thetaiotaomicron strain and a fusobacterium necrogenes strain against Clostridium perfringens in gnotobiotic mice and in fecal suspensions incubated in vitro. Infect Immun 1989; 57: 724-31.
15. Tancrède C, Azizi P, Raibaud P, Ducluzeau R. Conséquences de la destruction des barrières écologiques de la flore du tube digestif par les antibiotiques. Perturbations des relations entre l'hôte et les bactéries potentiellement pathogènes. Med Mal Infect 1977; 7: 145-9.
16. Van Der Waaij D, De Vries-Hospers H. The influence of antibiotics on gut colonization. J Antimicrob Chemother 1986; 18 Suppl C: 155-8.
17. Vollaard E, Clasenet H, Janssen A. The contribution of Escherichia coli to microbial colonization resistance. J Antimicrob Chemother 1990; 26: 411-8.
18. Vollaard E, Clasenet H, Janssen A, Wynne H. Influence of amoxycillin on microbial colonization resistance in healthy volunteers. A methodological study. J Antimicrob Chemother 1990; 25: 861-71.
19. Pecquet S, ANdremont A, Tancrede C. Selective antimicrobial modulation of the intestinal tract by norfloxacin in human volunteers and in gnotobiotic mice associated with a human fecal flora. Antimicrob Agents Chemother 1986; 29 Suppl 6: 1047-52.
20. Pecquet S, ANdremont A, Tancrede C. Effect of oral ofloxacin on fecal bacteria in human volunteers. Antimicrob Agents Chemother 1987; 31 Suppl 1: 124-5.
21. Berg R. Translocation of indigenous bacteria from the intestinal tract. In: Hentges DJ, ed. Human Intestinal Microflora in Health and Disease. New-York: Academic Press; 1983. p. 333-55.
22. Berg R. Bacterial translocation from the gastrointestinal tract. Trends in Microbiol 1995; 3: 149-54.
23. Youssef M, Corthier G, Goossens H, Tancrede C, Henry-Amar M, Andremont A. Comparative translocation of enteropathogenic Campylobacter spp. And Escherichia coli from the intestinal tract of gnotobiotic mice. Infect Immun 1987; 55 Suppl 4: 1019-21.
24. Tancrede CH, Andremont A. Bacterial translocation and gram-negative bacteremia in patients with hematological malignancies. J Infect Dis 1985; 152 Suppl 1: 99-103.
25. Rush B, Sori A, Murphy T, SMith S, Flanagan J, Machiedo G. Endotoxemia and bacteremia during hemorrhagic schock. Ann Surg 1988; 207: 549-52.
26. Ambrose N, Johnson M, Burdon D, Keighley M. Incidence of pathogenic bacteria from mesenteric lymph nodes and ileal serosa during crohn's disease surgery. J Surg 1984; 71: 623-5.
27. Vincent P, Colombel J, Lescut D, Fournier L, Savage C, Cortot A, et al. Bacterial translocation in patients with colorectal cancer. J Infect Dis 1988; 158: 1395-6.
28. Deitch E. Simple intestinal obstruction causes bacterial translocation in man. Arch Surg 1989; 124: 699-701.
29. Youssef M, Shurman A, Chachaty E, Bsoul A, Andremont A. Use of molecular typing to investigate bacterial translocation from the gastrointestinal tract in malnourished children with Gram-negative bacteremia. Clin Microbiol Infect 1998; 4: 70-4.
30. Bouhnik Y, Flourie B, POchart P, Marteau L, Rambaud JC. Oligosaccharides de synthèse, aspects nutritionnels. Cah Nutri Diet 1991; 26: 418-22.
31. Gournier-Chateau N, Larpent J, Castellanos M, Larpent J. Les Probiotiques en Alimentation Animale et Humaine. Paris: Lavoisier, Tec & Doc; 1994.
32. Pecquet S, Guillaumin D, Tancrede C, Andremont A. Kinetics of Saccharomyces cerevisiae elimination from the intestines of human volunteers and effect of this yeast on resistance to microbial colonization in gnotobiotic mice. Appl Environ Microbiol 1991; 57 Suppl 10: 3049-51.
33. Bartram HP, Scheppach W, Gerlach S, Ruckdeschel G, Kelber E, Kasper H. Does oygurt enriched with bifidobacterium longum affect colonic microbiology and fecal metabolites in healthy subjects. Am J Clin Nutr 1994; 59: 428-32.
34. Marteau P, Rambaud J. Potential of using lactic acid bacteria for therapy and immunomodulation in man. FEMS Microbiol Rev 1993; 12: 207-20.
35. Duval-Iflah Y, Chappuis J, Ducluzeau R, Raibaud P. Intraspecific interactions between Escherichia coli strains in human newborns and in gnotobiotic mice and piglets. Prog Fd Nutr Sci 1983; 7: 107-16.
36. McFarland L, Bernasconi P. Saccharomyces boulardii. A review of an innovative biotherapeutic agent. Microbiol Eco Health Dis 1993; 6: 157-71.
37. Corthier G, Lucas F, Jouvert S, Castex F. Effect of oral Saccharomyces boulardii treatment on the activity of Clostridium difficile toxins in mouse digestive tract. Toxicon 1992; 30: 1583-9.
38. Silva M, Jacobus N, Deneke C, Gorbach S. Antimicrobial substance from a human Lactobacillus strain. Antimicrob Agents Chemother 1987; 31: 1231-3.
39. Gorbach S, Goldin B. Nutrition and the gastro-intestinal microflora. Nutr Rev 1992; 50: 378-81.
40. Clasenet H, Vollaard E, Van Saene H. Long-term prophylaxis of infection by selective decontamination in leukopenia and in mechanical ventilation. Rev Infect Dis 1987; 9: 295-328.
41. Anonymous. Meta-analysis of randomised controled trials of selective decontamination of the digestive tract. Brit Med J 1993; 307: 525-32.
42. Heyland D, Cook D, Jaeschke R, Griffith L, Lee H, Guyatt G. Selective decontamination of the digestive tract. An Overview. Chest 1994; 105: 1221-9.
43. Kollef M. The role of selective tract decontamination on mortality and respiratory tract infections. A Meta-analysis. Chest 1994; 105: 1101-8.
44. ANdremont A, Sancho-Garnier H, Tancrede C. Epidemiology of intestinal colonization by members of the family Enterobacteriaceae highly resistant to erythromycin in a hematology-oncology unit. Antimicrob Agents Chemother 1986; 29 Suppl 6: 1104-7.
45. Prevot MH, ANdremont A, Sancho-Garnier H, Tancrede C. Epidemiology of intestinal colonization by members of the family Enterobacteriaceae resistant to cefotaxime in a hematology-oncology unit. Antimicrob Agents Chemother 1986; 30 Suppl 6: 945-7.
46. Courvalin P, Goldstein F, Philippon A, Sirot J. L'antibiogramme. Paris: MPC-Videom; 1985.
47. Corpet D. An evaluation of methods to assess the effect of antimicrobial residues on the human gut flora. Vet Microbiol 1993; 35: 199-212.
48. Chachaty E, Youssef MT, Bourneix C, Andremont A. Shedding of antibiotic-resistant members of the family Enterobacteriaceae in healthy residents of France and Jordan. Res Microbiol 1995; 146 Suppl 2: 175-82.
49. Lemozy J. La résistance des bactéries aux antibiotiques en population urbaine. Sci Tech Anim Lab 1976; 3: 170-1.
50. Langlois B, Dawson K, Cromwell G, Stahly T. Antibiotic resistance in pigs following a 13 years ban. J Anim Sci 1986; 62 Suppl 3: 18-32.
51. Lester S, Del Pilar Pla M, Wang F, Perez Schaeli I, O'Brien T. The carriage of Escherichia coli resistant to antimicrobial agents by healthychildren in Boston, Caracas, Venezuela, and in Qin Pu, China. N Engl J Med 1990; 323: 285-9.
52. London N, Nijsten R, Vanderbogaard A, Stobberingh E. Antibiotic resistance of faecal enterobacteriaceae isolated from healthy volunteers, a 15-week follow-up study. J Antimicrob Chemother 1993; 32: 83-91.
53. London N, Nijsten R, Mertens P, Vanderbogaard A, Stobberingh E. Effect of antibiotic therapy on the antibiotic resistance of faecal Escherichia coli in patients attending general practitioners. J Antimicrob Chemother 1994; 34: 239-46.
54. O'Brien T, Acar J, Medeiros A, Norton R, Goldstein F, Kent R. International comparison of prevalence of resistance to antibiotics. JAMA 1978; 239: 1518-23.
55. Woodford N, Johnson A, Morrison D, Speller D. Current perspectives on glycopeptide resistance. Clin Microbiol Rev 1995; 8: 585-615.
56. Jordens J, Bates J, Griffiths D. Faecal carriage and nosocomial spread of vancomycin resistant Enterococcus faecium. J Antimicrob Chemother 1994; 34: 515-28.
57. Gardner P, Smith D, Beer H, Moellering R. Recovery of resistance (R) factors from a drug-free community. Lancet 1969; 2: 774-6.
58. Mare I, Coetzee J. The incidence of transmissible drug resistance factors among strains of Escherichia coli in the pretoria area. South Afr Med J 1966: 980-1.
59. Mare I. Incidence of R factors among Gram-negative bacteria in drug-free human and animal communities. Nature 1968; 220: 1046-7.
60. Levy S, Marshall B, Schluederberg S. High frequency of antimicrobial resistance in human fecal flora. Antimicrob Agents Chemother 1988; 32: 1801-6.
61. Murray B, Renismer E, Dupont H. Emergence of high-level trimetoprim resistance in fecal Escherichia coli during oral adminsitration of trimethoprim or trimethoprim-sulfamethoxazole. N Engl J Med 1982; 306: 130-5.
62. Mac Gowan J. Antimicrobial resistance in hospital organisms and its relation to antimicrobial use. Rev Infect Dis 1983; 5: 1033-48.
63. Nijsten R, London N, Vandenbogaard A, Stobberingh E. Resistance in faecal Escherichia coli isolated from pigfarmers and abattoir workers. Epidemiol Infect 1994; 113: 45-52.
64. Parsonnet K, Kass E. Does prolonged exposure to antibiotic-resistant bacteria increase the rate of antibiotic-resistant infection? Antimicrob Agents Chemother 1987; 31: 911-4.
65. Chaslus-Dancla E. Experience of problems with other farmed animals than fish. In: Alderman CMD, ed. Chemotherpay in Aquaculture: from Theory to Reality. Paris: Office international des épizooties; 1992. p. 243-53.
66. Endtz H, Ruijs G, VanKingeren B, Jansen X, Van Der Reyden T, Mouton P. Quinolone resistance in campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine. J Antimicrob Chemother 1991; 27: 199-208.
67. Klare I, HEier H, Claus H, REissbrodt R, Witte W. Van A mediated high level glycopeptide resistance in Enterococcus faecium from animal husbandry. FEMS Microbiol Lett 1995; 125: 165-72.
68. Klare I, Badstubner D, Konstabel C, Bohme G, Claus H, Witte W. Decreased incidence of Van a-type vancomycin-resistant enterococci isolated from poultry meat and from fecal samples of humans in the community after discontinuation of avoparcin usage in animal husbandry. Microb Drug Resist 1999; 5 Suppl 1: 45-52.
69. Corpet D. Antibiotic residues and drug resistance in human intestinal flora. Antimicrob Agents Chemother 1987; 31 Suppl 4: 587-93.
70. Corpet DE. Antibiotic resistance from food. N Engl J Med 1988; 318 Suppl 18: 1206-7.
71. Corpet D. Pourquoi des bactéries résistantes dans la flore de l'homme: Résidus antibiotiques ou aliments contaminés? Med Nutr 1988; 26: 224-30.
72. ROlland R, Hausfater G, Marshall B, Levy S. Antibiotic-resistant bacteria in wild primates: Increased prevalence in baboons feeding on human refuse. Appl Environ Microbiol 1985; 49: 791-4.
73. Chachaty E, Bourneix C, Renard S, Bonnay M, Andremont A. Shedding of Clostridium difficile, fecal β-lactamase activity, and gastrointestinal symptoms in 51 volunteers treated with oral cefixime. Antimicrob Agents Chemother 1993; 37 Suppl 7: 1432-5.
74. Guiot HF, Peetermans WE, Sebens FW. Isolation of vancomycin-resistant enterococci in haematologic patients. Eur J Clin Microbiol Infect Dis 1991; 10 Suppl 1: 32-4.
75. LIvornese L, Dias S, Saniel C, Remanowsk B, Taylor S, May P, et al. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Int Med 1992; 117: 112-6.
76. Rubin L, Tucci V, Cercenado E, Elioupoulos G, Isenberg H. Vancomycin-resistant Enterococcus faecium in hospitalized children. Infect Control Hosp Epidemiol 1992; 13: 700-5.
77. Chadwick PR, Woodford N, Kaczmarski EB, Gray S, Barrell RA, Oppenheim BA. Glycopeptide-resistant enterococci isolated from uncooked meat [letter]. J Antimicrob Chemother 1996; 38 Suppl 5: 908-9.
78. Perrier-Gros-Claude J, Courrier P, Bréard J, Vignot J, Masseront T, Garin D, et al. Entérocoques résistants aux glycopeptides dans les viandes. BEH 1998; Suppl 12: 50-1.
79. Garau J, Xercavins M, Rodriguez-Carballeira M, Gomez-Vera JR, Coll I, Vidal D, et al. Emergence and dissemination of quinolone-resistant Escherichia coli in the community [process citation]. Antimicrob Agents Chemother 1999; 43 Suppl 11: 2736-41.
80. Wegener HC. The consequences for food safety of the use of fluoroquinolones in food animals [editorial, comment]. N Engl J Med 1999; 340 Suppl 20: 1581-2.
81. Benveniste R, Davies J. Aminoglycoside antibiotic-inactivation enzymes in actinomycetes similar to those present in clinical isolates of antibiotic resistant bacteria. Proc Nat Acad Sci USA 1973; 70: 2276-80.
82. Walker J, Skorvaga M. Phosphorylation of streptomycin and dihidrostreptomycin y streptomyces enzymatic synthesis of different diphosphorylated derivatives. J Biol Chem 1973; 248: 2435-40.
83. Davies J. Another look at antibiotic resistance 1991 Fred Griffith Review Lecture. J Gen Microbiol 1992; 138: 1553-9.
84. Shaw WV. Bacterial resistance to chloramphenicol. Br Med Bull 1984; 40: 36-41.
85. Davies J. Inactivation of antibiotics and the dissemination of resistance genes. Science 1994; 264: 375-82.
86. Coque JJ, Liras P, Martin JF. genes for a β-lactamase, a peni cillin-binding protein and a transmembrane protein are clustered with the cephamycin biosynthetic genes in Nocardia lactamdurans. EMBO J 1993; 12 Suppl 2: 631-9.
87. Marshall CG, Lessard IA, Park I, Wright GD. Glycopeptide antibiotic resistance genes in glycopeptide-producing organisms. Antimicrob Agents Chemother 1998; 42 Suppl 9: 2215-20.
88. Pang Y, BRown B, Streingrube V, Wallace Jr R, Roberts M. Tetracycline resistance determinants in Mycobacterium and Streptomyces species. Antimicrob Agents Chemother 1994; 38: 1408-12.
89. Doucet-Populaire F, Trieu-Cuot P, Dosbaa I, ANdremont A, Courvalin P. Inducible transfer of conjugative transposon Tn1545 from Enterococcus faecalis to Listeria monocytogenes in the digestive tracts of gnotobiotic mice. Antimicrob Agents Chemother 1991; 35 Suppl 1: 185-7.
90. Doucet-Populaire F, Trieu-Cuot P, ANdremont A, Courvalin P. Conjugal transfer of plasmid DNA from Enterococcus faecalis to Escherichia coli in digestive tracts of gnotobiotic mice. Antimicrob Agents Chemother 1992; 36 Suppl 2: 502-4.
91. Davies J, Webb V, Davies J. Antibiotic preparations contain DNA: A source of drug resistance genes? Antimicrob Agents Chemother 1993; 37: 2379-84.
92. Magnet S, Courvalin P, Lambert T. Activation of the cryptic aac(6')-Iy aminoglycoside resistance gene of Salmonella by a chromosomal deletion generating a transcriptional fusion. J Bacteriol 1999; 181 Suppl 21: 6650-5.
93. Stokes H, Hall R. A novel family of potentially mobile DNA elements encoding site-specific gene-integration function: Integrons. Mol Microbiol 1989; 3: 1669-83.
94. Levesque C, Brassard S, Lapointe J, Roy P. Diversity and relative strengh of tandem promoters for the antibiotic-resistance genes of several integrons. Gene 1994; 142: 2379-84.
95. ANdremont A, GErbaud G, Tancrede C, Courvalin P. Plasmid-Mediated susceptibility to intestinal microbial antagonisms in Escherichia coli. Infect Immun 1985; 49 Suppl 3: 751-5.
96. Duval-Iflah Y, Raibaud P, Tancrede C, Rousseau M. R-plasmid transfer from Serratia liquefaciens to Escherichia coli in vitro and in vivo in the digestive tract of gnotobiotic mice associated with human fecal flora. Infect Immun 1980; 28 Suppl 3: 981-90.
97. Austin DJ, Kristinsson KG, Anderson RM. The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proc Nat Acad Sci USA 1999; 96 Suppl 3: 1152-6.
98. Levy S. The Antibiotic Paradox: how Miracle Drugs are Destroying the Miracle. New York: Plenum Press; 1992.
99. Remington J, Schimpff S. Please don't eat the salads. N Engl J Med 1981; 304: 433-4.